valproic acid has been researched along with ginsenosides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Liao, J; Ouyang, D; Zeng, X; Zhou, L | 1 |
| Chen, L; Ouyang, D; Rao, T; Tan, Z; Zeng, X; Zhou, G; Zhou, L | 1 |
2 other study(ies) available for valproic acid and ginsenosides
| Article | Year |
|---|---|
Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis.
Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Ginsenosides; Homeostasis; Iron; Liver; Male; Microscopy, Electron, Transmission; Oxidative Stress; Peroxisomes; Rats; Rats, Sprague-Dawley; Valproic Acid | 2020 |
Evaluating the protective effects of individual or combined ginsenoside compound K and the downregulation of soluble epoxide hydrolase expression against sodium valproate-induced liver cell damage.
Topics: Antioxidants; Cell Line; Chemical and Drug Induced Liver Injury; Down-Regulation; Epoxide Hydrolases; Ginsenosides; Hepatocytes; Humans; Liver; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; RNA, Small Interfering; Valproic Acid | 2021 |